There are 2934 resources available
Can we combine radiotherapy with I-O?
Presenter: Rafal Dziadziuszko
Session: Optimal delivery of immuno-oncology (I-O) in advanced NSCLC
Resources:
Slides
Webcast
4839 - Bevacizumab plus chemotherapy versus chemotherapy alone as first-line treatment for patients with RAS mutant unresectable colorectal liver-limited metastases- A single center randomized control trial
Presenter: Jianmin Xu
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
3057 - Tailored ImmunoTherapy Approach with Nivolumab in advanced Renal Cell Carcinoma (TITAN-RCC)
Presenter: Marc-Oliver Grimm
Session: Proffered Paper 2 – Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Proffered Paper 2 – Genitourinary tumours, non-prostate - Invited Discussant LBA56 and LBA57
Presenter: Cristina Suárez
Session: Proffered Paper 2 – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
2454 - EONS - Development of Core Indicators of Non-Specialist Palliative Care in Hospitals – An International Modified Delphi Study
Presenter: Mary Nevin
Session: EONS 12: Recent trends in palliative care
Resources:
Abstract
Slides
5966 - EONS - Opinions of palliative care patients and nurses regarding dignified care
Presenter: Yasemin Eskigulek
Session: EONS 12: Recent trends in palliative care
Resources:
Abstract
Slides
Webcast
4298 - 3-year relapse-free survival (RFS), overall survival (OS) and long-term toxicity of (neo)adjuvant ipilimumab (IPI) + nivolumab (NIVO) in macroscopic stage III melanoma (OpACIN trial)
Presenter: Christian Blank
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
4800 - Plasma proteomics in patients with metastatic cutaneous melanoma treated with immune checkpoint inhibitors
Presenter: Hanna Eriksson
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
5704 - Safety and Efficacy of TRIplet combination of Nivolumab (N) with Dabrafenib (D) and Trametinib (T) [TRIDeNT] in Patients (pts) with BRAF-mutated Metastatic Melanoma (MM): A Single Center Phase II Study
Presenter: Elizabeth Burton
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
4560 - Cell Phenotypes Associated with Response and Toxicity Defined by High Resolution Flow Cytometry in Melanoma Patients receiving Checkpoint Inhibition
Presenter: Jeffrey Weber
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract